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Glucose depletionThe catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) plays an essential role in double-strand break
repair by initially recognizing and binding to DNA breaks. Here, we show that DNA-PKcs interacts with the regu-
latory γ1 subunit of AMP-activated protein kinase (AMPK), a heterotrimeric enzyme that has been proposed to
function as a “fuel gauge” tomonitor changes in the energy status of cells and is controlled by the upstreamkinases
LKB1 and Ca2+/calmodulin-dependent kinase kinase (CaMKK). In co-immunoprecipitation analyses, DNA-PKcs
and AMPKγ1 interacted physically in DNA-PKcs-proﬁcient M059K cells but not in DNA-PKcs-deﬁcient M059J
cells. Glucose deprivation-stimulated phosphorylation of AMPKα on Thr172 and of acetyl-CoA carboxylase
(ACC), a downstream target of AMPK, is substantially reduced in M059J cells comparedwith M059K cells. The in-
hibition or down-regulation of DNA-PKcs by the DNA-PKcs inhibitors, wortmannin and Nu7441, or by DNA-PKcs
siRNA caused amarked reduction in AMPK phosphorylation, AMPK activity, and ACC phosphorylation in response
to glucose depletion in M059K, WI38, and IMR90 cells. In addition, DNA–DNA-PKcs−/−mouse embryonic ﬁbro-
blasts (MEFs) exhibited decreased AMPK activation in response to glucose-free conditions. Furthermore, the
knockdown of DNA-PKcs led to the suppression of AMPK (Thr172) phosphorylation in LKB1-deﬁcient HeLa cells
under glucose deprivation. Taken together, these ﬁndings support the positive regulation of AMPK activation by
DNA-PKcs under glucose-deprived conditions in mammalian cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
DNA-dependent protein kinase (DNA-PK) is a nuclear serine/
threonine protein kinase that is activated by DNA double-strand
breaks (DSBs) [1–3]. DNA-PK plays a central role in nonhomologous
DNA end-joining (NHEJ) by initially recognizing and binding to dam-
aged DNA and then targeting other repair activities to the site of
damage. DNA-PK is composed of a 470-kDa catalytic subunit (DNA-PKcs)endent protein kinase; AMPK,
bunit of AMP-activated protein
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rights reserved.and Ku70/Ku80 heterodimeric regulatory components [4,5]. DNA-PKcs
belongs to the family of phosphatidyl-inositol 3-OH kinase-related ki-
nases (PIKKs), which also includes ataxia telangiectasia mutated (ATM)
and ATM- and RAD-3-related (ATR) kinase in mammals [4,6,7]. Mem-
bers of this family are high-molecular-weight polypeptides sharing a
conserved C-terminal region with homology to the catalytic domain of
phosphatidylinositol-3-OH kinase. ATM, ATR, and DNA-PKcs are impli-
cated in cellular responses to DSBs, resulting in the phosphorylation of
targets such as H2AX, Chk1, Chk2, Nbs1, and MDC1 [8].
AMP-activated protein kinase (AMPK) is a serine/threonine protein
kinase that serves as an energy sensor in all eukaryotic cell types [9].
AMPK is a heterotrimer consisting of a catalyticα subunit and two regu-
latory and targeting subunits, β and γ. In mammals, there are twoα sub-
units, threeγ subunits, and twoβ subunits (α1,α2,γ1,γ2,γ3,β1 andβ2)
[10]. The α subunits each contain an N-terminal catalytic core (1–312)
and a C-terminal sequence (313–548) responsible for autoregulation
and binding to the β and γ subunits [11]. The γ subunits each contain
four tandem cystathione β-synthase (CBS) domains that together bind
twomolecules of AMPand allow the kinase complex to sense adenine nu-
cleotide levels. Theβ subunits have been reported to serve as a scaffold for
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such as the cell membrane, through myristoylation of its N-terminus
[12,13], and to intracellular glycogen, through a glycogen binding domain
[14]. The binding of AMP to the CBS domain of the AMPKγ subunit leads
to activation of the AMPK complex, and this activation is antagonized by a
high concentration of ATP, enabling the system tomonitor changes in the
cellular AMP:ATP ratio [15,16]. When activated by a rise in the cellular
AMP concentration, AMPK inhibits anabolic pathways and promotes cat-
abolic pathways to restore cellular energy levels. The activation of AMPK
leads to the phosphorylation of a number of proteins, resulting in in-
creased glucose uptake, glycolysis, and fatty acid oxidation plus the si-
multaneous inhibition of fatty acid synthesis, cholesterol synthesis, and
glucose production [17–19].
At least two kinases have been shown to phosphorylate AMPK:
LKB1, a tumor suppressor kinase, in complex with two accessory sub-
units, STRAD and MO25 [20–23]; and Ca2+-calmodulin-dependent
protein kinase β (CaMKKβ) [24–26]. LKB1 is not stimulated by AMP
but is constitutively active [23,27,28]. In vitro studies have suggested
that the binding of AMP to AMPK is likely to be the principle regula-
tory mechanism for stimulating the phosphorylation of AMPK by
LKB1 [20]. AMPK can also be activated in an AMP-independent man-
ner, by hyperosmotic stress or with the antidiabetic drug metformin
[29]. The ﬁnding that CAMKKβ acts upstream of AMPK suggests that
an increase of intracellular Ca2+ may act as a second pathway to acti-
vate AMPK, in addition to changes of the AMP:ATP ratio.
In the present study, we investigated the possible role of DNA-
PKcs in the activation of AMPK, using DNA-PKcs-proﬁcient and
DNA-PKcs-deﬁcient human glioma cells. We ﬁrst showed that DNA-
PKcs could interact with AMPKγ1. We observed that AMPK and ACC
phosphorylation aswell as AMPK activitywere signiﬁcantly suppressed
in DNA-PKcs-deﬁcient M059J cells in response to glucose depletion. In
addition, the knockdown or inhibition of DNA-PKcs by, respectively, a
DNA-PKcs-speciﬁc small interfering RNA (siRNA) or wortmannin and
Nu7441, chemical inhibitors of DNA-PKcs, reduced the phosphorylation
of AMPK. In addition, DNA-PKcs−/− mouse embryonic ﬁbroblasts
(MEFs) exhibited decreased AMPK activation in response to glucose-
free conditions. Finally, in LKB1-deﬁcient HeLa cells, the knockdown
of DNA-PKcs led to the suppression of AMPK activation. Our com-
bined results suggest that DNA-PKcs may play a physiological role
in the activation of AMPK in mammalian cells in response to energy
depletion.2. Materials and methods
2.1. Reagents and cell culture
Human glioma M059K and M059J cells were maintained in
Dulbecco's modiﬁed Eagle medium with Ham's F-12 nutrient mixture
(DMEM/F12) (1:1) supplemented with 10% fetal bovine serum (FBS),
penicillin (100 U/ml), and streptomycin (100 μg/ml) (Invitrogen,
Carlsbad, CA). HeLa human cervical cancer cells were maintained in
DMEM containing 10% FBS, penicillin (100 U/ml), and streptomycin
(100 μg/ml) (Invitrogen). Human primary ﬁbroblasts IMR90 and
WI38 cells were maintained in Earle's MEM containing 10% FBS,
penicillin (100 U/ml), and streptomycin (100 μg/ml) (Invitrogen).
Cells were maintained in a humidiﬁed incubator with an atmo-
sphere of 5% CO2 at 37 °C. All cell lines were from the American
Type Culture Collection (ATCC, Rockville, MD). DNA-PKcs+/+ and
DNA-PKcs−/− MEFs were kindly provided by Prof. Penny A. Jeggo
(Genome damage and Stability Center, University of Sussex, UK).
DNA-PKcs+/+ and DNA-PKcs−/− MEFs were grown in Dulbecco's
modiﬁed Eagle's medium supplemented with 10% fetal calf serum,
100 units/ml penicillin, and 100 μg/ml streptomycin. Wortmannin
was from Cell Signaling Technology (Danvers, MA). Nu7441 and
Ku55933 were from TOCRIS bioscience (Bristol, UK).2.2. Antibodies
Monoclonal antibodies against DNA-PKcs, AMPKγ1, and phospho-
DNA-PKcs on T2609 were from Abcam (Cambridge, MA). Monoclonal
antibodies against AMPKα and phospho-AMPKα on Thr172, mTOR,
ATM, LKB1 and polyclonal antibodies against phospho-acetyl-CoA car-
boxylase on Ser79, were from Cell Signaling Technology. Antibodies to
α-tubulin were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
2.3. Yeast two-hybrid assay
A yeast two-hybrid screen was performed using a Matchmaker
GAL4 Two-Hybrid System 3 (Clontech, Mountain View, CA) following
the manufacturer's directions. Saccharomyces cerevisiae strain AH109,
containing distinct ADE2, HIS3, lacZ and MEL1 reporter constructs,
was used for the assay. The AH109 strain was transformed with the bait
plasmid pGBT9, encoding an in-frame fusion of the GAL4 DNA-binding
domainwithDNA-PKcs (amino acid residues 2908–3538). Transformants
were plated onto selective SD medium lacking Trp and incubated for
3–5 days at 30 °C. Yeast strains containing the bait plasmid were
transformedwith aprostate cDNA library fused to theGAL4 activationdo-
main in pACT2 vector. Transformants were plated on selective SD medi-
um lacking Leu, Trp, and His and were further screened on SD medium
with X-α-Gal to identify the expression of α-galactosidase, as indicated
by the formation of blue colonies. PlasmidDNAwas isolated frompositive
clones and sequenced to identify the genes encoding the interacting pro-
teins. The sequences were analyzed using NCBI's BLAST program. One of
the positive clones, identiﬁed as AMPKγ1, was cloned into pACT2 vector
and transformed into Escherichia coli DH5α. After expression was con-
ﬁrmed, AMPKγ1 in pACT2 was transformed into yeast strain AH109
containing the bait plasmid. Assayswere repeated for growth on selective
medium and blue colony formation, and the clone was reconﬁrmed by
sequencing.
2.4. Immunoprecipitation
Whole-cell lysates were obtained by incubating cells in lysis buffer
(25 mM Tris, pH 7.2, 150 mM NaCl, 5 mM MgCl2, 0.5% NP-40, 1 mM
DTT, 5% glycerol, 1 mM phenylmethanesulfonyl ﬂuoride, 2 μg/ml
pepstatin, 2 μg/ml leupeptin, and 2 μg/ml aprotinin) for 30 min at
4 °C. Cellular debris was removed by centrifugation at 13,000 ×g for
30 min at 4 °C. One milligram of protein from the cell lysates was
immunoprecipitated overnight at 4°C, using anti-DNA-PKcs and
anti-AMPKγ1 antibodies and protein G-agarose beads (Amersham
Biosciences, Piscataway, NJ). The beads were washed extensively
with lysis buffer and boiled in SDS sample buffer; the proteins were
fractionated by SDS-PAGE and analyzed by immunoblotting with
anti-DNA-PKcs, anti-AMPKα, and anti-AMPKγ1 antibodies.
2.5. Western blot
Cultured cells were washed with phosphate-buffered saline and
lysed at 0 °C for 30 min in lysis buffer (20 mM HEPES, pH 7.4,
2 mM EGTA, 50 mM glycerol phosphate, 1% Triton X-100, 10% glyc-
erol, 1 mM dithiothreitol, 1 mM phenylmethanesulfonyl ﬂuoride,
10 μg/ml leupeptin, 10 μg/ml aprotinin, 1 mM Na3VO4, and 5 mM
NaF). Cellular protein content was quantitated using a dye-binding
microassay (Bio-Rad, Hercules, CA). Protein samples (20 μg) were
boiled for 5 min in Laemmli sample buffer, loaded onto 10% SDS-
polyacrylamide gels, and electrophoresed. The separated proteins
were electroblotted onto Bio-trace PVDF membranes (PALL Life Sci-
ences, Pensacola, FL, UAS) and the membranes were blocked with
Tris-buffered saline (10 mM Tris–HCl, pH 7.6, 150 mMNaCl) containing
0.1% Tween-20 and 5% milk. The membranes were incubated for over-
night with the appropriate primary antibodies and α-tubulin antibody,
diluted according to the manufacturer's protocol, in blocking buffer.
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secondary antibodies (1:4000) in blocking buffer, and washed again.
The blotted proteins were detected using an enhanced chemilumines-
cence detection system (iNtRON Biotech, Seoul, Korea).
2.6. Small interfering RNA (siRNA)
DNA-PKcs siRNA (#1) was purchased from Santa Cruz Biotech-
nology (sc-35200). This DNA-PKcs siRNA #1 contains two different
siRNA sequences of DNA-PKcs. The sequences of sense siRNAs are
as follows: 5′-GAU CGCACCUUACUCUGUUdTdT-3′ for the DNA-PKcs
gene (nt 352–370) and 5′-CUU UAUGGUGGCCAUGGAGdTdT-3′ for the
DNA-PKcs gene (nt 11,836–11,854). Another DNA-PKcs siRNA (#2) was
designed using siRNA target Finder program (Ambion, Austin, TX). The
sequence of the DNA-PKcs #2 duplexes was 5′-UUGGAGAAUACGACGUC
CUUU-3′ for the DNA-PKcs gene (nt 8,853-8871). M059K and HeLa cells
were transfected using Lipofectamine RNAiMAX (Invitrogen) according
to the manufacturer's protocol. Scrambled siRNA was purchased from
Bioneer (Daejeon, Korea) and was used as the negative control.
2.7. AMPK assay
AMPK was immunoprecipitated from cell extracts prepared in
triplicate, each representing a pooling of two wells treated under
identical conditions. Whole-cell lysates containing 200 μg of protein
were incubated with protein G-sepharose beads (Amersham Biosci-
ences) and anti-AMPKα antibody (Cell Signaling). Following 2 h incuba-
tion at 4 °C, the extracts were centrifuged for 20 s at 12,000 rpm to
gently pellet the beads. The supernatant was carefully removed, and the
beads were washed once with buffer containing 1% Triton X-100 and
then two times with the same buffer but containing no detergent. The
beadswere resuspended in 50 μl of this buffer, and the resulting immune
complexes were immediately assayed, in duplicate, for AMPK activity.
The AMPK activity was determined by measuring the incorporation of
32P into 5 μg synthetic peptide substrate SAMS (HMRSAMSGLHLVKRR),
using 5 μCi [γ-32P]ATP [30]. The assay mixtures were incubated at 30 °C
for 10 min, and the reaction was terminated by spotting the mixtures
onto P-81 phosphocellulose paper and washing 3×5 min in 1% phos-
phoric acid. The samples were dried, and the incorporation of labeled
phosphate was quantiﬁed using a liquid scintillation counter (Packard
Instruments, Meriden, CT).
2.8. Data analysis
All values shown represent means±S.D. Where indicated, we
performed analyses of signiﬁcance by the two-tailed Student's t-test.
We considered P 0.05 (indicated * in ﬁgures) as signiﬁcant and P 0.01
(**) as highly signiﬁcant.
3. Results
3.1. Identiﬁcation of AMPKγ1 as a DNA-PKcs-interacting protein
To explore DNA-PKcs-interacting proteins, we performed yeast
two-hybrid screening analysis using a GAL4 transcription activation do-
main (AD)-fused human prostate cDNA library. With GAL4 DNA bind-
ing domain (BD)-fused the C-terminus of DNA-PKcs (amino acids
2908 to 3538) as the bait, we identiﬁed several independent real posi-
tive clones out of 2×106 transformants; real positive clones exhibit a
blue color on media containing X-gal, growth on medium lacking leu-
cine, tryptophan, and histidine. Sequence analysis of cDNAs from the
positive colonies identiﬁed AMPKγ1. To further conﬁrm an interaction
between AMPKγ1 and DNA-PKcs, we cotransfected yeast cells with
the DNA-PKcs (amino acids 2908 to 3538) and AMPKγ1 constructs.
Blue–white color selection in medium lacking leucine, tryptophan,
and histidine was used to identify the transformed colonies (data notshown), suggesting that the AMPKγ1 is sufﬁcient for DNA-PKcs binding
in the yeast two-hybrid system.
We performed immunoprecipitation experiments to determine
whether DNA-PKcs would interact with AMPKγ1 in DNA-PKcs-
proﬁcient M059K and in DNA-PKcs-deﬁcient M059J cells. After the
M059K andM059J cells were cultured in normal or glucose-freemedium
for 12 h, the cells were lysed. The proteins were immunoprecipitated
from the lysate with a DNA-PKcs-speciﬁc antibody and were subjected
to immunoblotting with an anti-AMPKγ1 antibody, revealing that
endogenous DNA-PKcs was bound to AMPKγ1 in M059K cells but
not in M059J cells. Glucose-free conditions did not signiﬁcantly
change the amount of DNA-PKcs bound to AMPKγ1 (Fig. 1A). In a re-
ciprocal co-immunoprecipitation assay with anti-AMPKγ1 antibody,
endogenous DNA-PKcs was readily immunoprecipitated from the
cell lysates (Fig. 1B). We also conﬁrmed that endogenous AMPKγ1
was not bound to DNA-PKcs in M059J cells. The binding was speciﬁc,
as noDNA-PKcswas detected in samples immunoprecipitatedwith rab-
bit IgG. These results identify AMPKγ1 as an endogenous interacting
partner for DNA-PKcs.
To further investigate whether DNA-PKcs regulates AMPK com-
plex association under normal and glucose-deprived conditions, we
performed immunoprecipitation experiments. After M059K and
M059J cells were cultured in the presence or absence of glucose,
the cells were lysed. The proteins were immunoprecipitated from
the lysate with an anti-AMPKγ1 antibody and were subjected to im-
munoblotting with an anti-AMPKα antibody. Under our experimen-
tal conditions, endogenous AMPKγ1 was bound to AMPKα1 in both
M059K and M059J cells (Supplementary Fig. S1), indicating that
DNA-PKcs did not affect AMPK complex association under normal
and glucose-deprived conditions.
3.2. DNA-PK contribute to the glucose deprivation-induced AMPK
phosphorylation in human glioma cells
Energy depletion, deﬁned as an increase in the AMP/ATP ratio,
can be caused by a variety of factors such as glucose deprivation,
hypoxia, and oxidative stress [13]. The cellular AMP/ATP ratio is
one of the major determinants of AMPK activity, and thus we tested
the ability of DNA-PKcs-deﬁcient and DNA-PKcs-proﬁcient cells to acti-
vate AMPK under glucose-deprived conditions. DNA-PKcs-proﬁcient
M059K and DNA-PKcs-deﬁcient M059J human glioma cells were cul-
tured in glucose-free conditions for 0, 6, 12, and 24 h.Whole-cell lysates
were prepared by a rapid lysis procedure and were subjected to immu-
noblottingwith anti-phospho-Thr172-AMPKα antibody. The blotswere
re-probedwith anti-AMPKα and anti-DNA-PKcs antibodies. AMPKphos-
phorylation at Thr172 was signiﬁcantly greater in M059K cells than in
M059J cells under glucose deprivation (Fig. 2A, B). Similarly, when
both cell typeswere culturedwith a series of decreasing glucose concen-
trations for 12 h, the absence of glucose had a greater effect on AMPKα
phosphorylation in M059K cells than in M059J cells (Fig. 2C, D), while
the expression level of total AMPKα remained constant. AMPK activity
is indicated by the phosphorylation level of Ser79 in its critical substrate
ACC, which is the rate-limiting enzyme of long-chain fatty acid synthesis
[31]. Thus, we also analyzed the phosphorylation of ACC as a marker of
AMPK activity. We observed that both basal and stimulated ACC phos-
phorylation at Ser79 were higher in M059K cells than in M059J cells
(Fig. 2A, 3rd panel), suggesting that DNA-PK might be involved in
AMPK activation. Because LKB1 is an important upstream kinase active
on AMPK [14], we compared the LKB1 expression levels between
M059K and M059J cells. We saw no differences in the expression level
of LKB1 between M059K and M059J cells (Fig. 2A, 4th panel); thus,
the different patterns of AMPK activity between these cells cannot be
attributed mainly to the expression of LKB1. We also checked whether
glucose depletion affected DNA-PKcs phosphorylation; however, DNA-
PKcs was not phosphorylated in M059K cells in response to glucose
deprivation (Fig. 2A, 6th panel).
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tured in the presence or absence of glucose for 24 h, and then whole-cell lysates were prepared. Proteins were immunoprecipitated from the lysates with anti-DNA-PKcs antibody,
and the immunoprecipitates were subjected to immunoblot analysis with an antibody speciﬁc for AMPKγ1 or DNA-PKcs. (B) Whole-cell lysates prepared from M059K and M059J
cells, maintained in the presence or absence of glucose for 12 h, were immunoprecipitated with monoclonal anti-AMPKγ1 antibody or control immunoglobulin (normal rabbit IgG),
and the resulting precipitates were immunoblotted with an antibody speciﬁc for DNA-PKcs or AMPKγ1.
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Fig. 2. DNA-PK contributes to the phosphorylation AMPK in response to glucose deprivation. (A) M059K andM059J human glioma cells were cultured under glucose-free conditions
for the indicated time periods. Whole-cell lysates were prepared and subjected to immunoblotting with anti-phospho-AMPKα, anti-AMPKα, anti-phospho-ACC, anti-DNA-PKcs,
anti-phospho-DNA-PKcs, and anti-α-tubulin antibodies. (B) The amount of phospho-AMPKα was quantiﬁed by densitometry and corrected for the amount of AMPKα in the cor-
responding lysate. The data shown are the mean s.d. from three separate experiments. **p 0.01. (C) M059J and M059K cells were incubated in 17.5, 10, 1, and 0 mM glucose for
24 h. Whole-cell lysates were prepared and subjected to immunoblotting with anti-phospho-AMPKα, anti-AMPKα, anti-phospho-ACC, and anti-α-tubulin antibodies. (D) The
amount of phospho-AMPKα was quantiﬁed by densitometry and corrected for the amount of AMPKα in the corresponding lysate. The data shown are the mean±s.d. from
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2103P.N. Amatya et al. / Biochimica et Biophysica Acta 1823 (2012) 2099–2108Phosphorylation of AMPK has been recently been observed fol-
lowing DNA damage [32,33]. This phosphorylation occurs indepen-
dent of LKB1, but is dependent upon DNA damage sensor, ATM.
Since DNA-PKcs is activated by DNA damage induced by both ionizing
and UV radiation and is regarded as a DNA damage sensor, we exam-
ined the effect of DNA-PKcs on ionizing radiation-induced AMPK
phosphorylation. At the indicated time points following ionizing radi-
ation, whole-cell lysates were prepared and analyzed for the expres-
sion levels of phosphorylated AMPK by immunoblotting. The results
showed that the AMPK phosphorylation at Thr172 was signiﬁcantly
greater in M059K cells than in M059J cells in response to ionizing ra-
diation (Supplementary Fig. S2), indicating that DNA-PKcs also con-
tributes to the DNA damage-induced AMPK activation.
3.3. DNA-PK positively regulates AMPK activity in response to Glucose
deprivation
To further explore the role of DNA-PKcs in AMPK activation, we
cultured both M059J and M059K cells with and without glucose,
immunoprecipitated total AMPK from the cell lysates, and assayed
the phosphorylation activity of the immune complex, using a SAMS
peptide assay. As shown in Fig. 3A, the basal AMPK activities of
M059J and M059K cells were 995 22 and 1020 25 cpm, respectively.
However, AMPK activity signiﬁcantly increased in M059K cells after
the depletion of glucose for 12 h compared with that in the M059J
cells. The AMPK activities were 1160 26 and 1480 36 cpm in M059J
and M059K cells exposed to glucose depletion, respectively.
We next investigated the effect of a reduced level of DNA-PKcs on
glucose deprivation-stimulated AMPK activity by transfecting M059K
cells with control siRNA or DNA-PKcs siRNA. M059K cells were
transfected with control siRNA or DNA-PKcs siRNAs. After 48 h, a sig-
niﬁcant decrease in the DNA-PKcs mRNA level was conﬁrmed by
RT-PCR (data not shown), and a decrease in the protein level of
more than 80% was observed by immunoblotting (example, Fig. 4C).
The AMPK activity after DNA-PKcs-siRNA transfection was next ex-
amined. The results showed that the M059K cells transfected with
the DNA-PKcs-siRNA had signiﬁcantly lower AMPK activity than0
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transfected cells was increased by approximately 46% (1010 22
versus 1470 31) with glucose deprivation, whereas the AMPK ac-
tivity was increased by only 24% (820 19 versus 1020 27) in the
DNA-PKcs-knockdown cells under the same conditions (Fig. 3B).
These results suggest that DNA-PKcs increases glucose deprivation-
stimulated AMPK activity.
3.4. Glucose deprivation-stimulated phosphorylation of AMPK is decreased
by inhibition or knockdown of DNA-PKcs
To explore its role in the phosphorylation of AMPK under glucose-
deprived conditions, the activity of DNA-PKcs was inhibited using
wortmannin, a potent and irreversible inhibitor of the enzyme, or the
level of DNA-PKcs was knocked down using siRNA. We initially investi-
gated the effect of wortmannin on glucose deprivation-induced AMPK
phosphorylation in M059K cells treated with 20 μM wortmannin for
1 h and then maintained under glucose-free conditions for different
amounts of time. Whole-cell lysates were prepared and analyzed by im-
munoblotting. The increase in AMPK phosphorylation stimulated by glu-
cose deprivation was less in wortmannin-treated cells than in untreated
control cells (Fig. 4A, B). These results imply that DNA-PKcs contributes
to the phosphorylation of AMPK under glucose-free conditions. Howev-
er, wortmannin also inhibits other PI3 kinases such as ATM. ATM phos-
phorylate the AMPK in response to insulin-like growth fator-1 (IGF-1)
[34] and 5-aminoimidazoe-4-carboxamide-1-β-4-ribofuranoside
(AICAR) [35], independently of LKB1. Thus, we used highly speciﬁc
small-molecule inhibitors of DNA-PKcs (Nu7441) and ATM (Ku55933).
We found that treatment of Nu7441 and Ku55933 caused decreased
phosphorylation AMPK following glucose deprivation, and both inhibi-
tors were equally effective in the suppression of the AMPK activation
under glucose-depleted condition (Supplementary Fig. S3). Thus, DNA-
PKcs and ATMmay redundantly the participation of the phosphorylation
of AMPK in response in response to glucose depletion.
To further determine whether DNA-PKcs is involved in the phos-
phorylation of AMPK, we tested the effect of DNA-PKcs knockdown on
glucose deprivation-induced AMPK phosphorylation in M059K cells.- + - +
0
200
400
600
800
1000
1200
1400
1600
A
M
PK
 a
ct
iv
ity
 (C
PM
)
lucose free
Control siRNA DNA-PK siRNA #1
****
B
ells. (A) M059J and M059K cells were maintained in the absence or presence of glucose
of the immune complexes was measured using a SAMS peptide assay. Each value is the
ere transfected with control siRNA or DNA-PKcs siRNA #1. After 48 h, the cells were
and AMPK was immunoprecipitated. The activity of the immune complexes was mea-
ents. **pb0.01.
p-AMPKα (Thr172)
α-tubulin
0      6      12     24            0     6     12    24 ( hr)   
p-ACC (Ser79)
Glucose free
AMPKα
DMSO                      Wortmannin
0
0.3
0.6
0.9
0 6 12 24 hr
DMSO
Wortmannin
Glucose free
0 6 12 24 hr
Glucose free
**
**
ph
os
ph
o-
A
M
PK
α
(n
or
ma
liz
ed
 in
ten
sit
y)
ph
os
ph
o-
A
M
PK
α
(n
or
ma
liz
ed
 in
ten
sit
y)
p-AMPKα (Thr172)
AMPKα
Control siRNA      DNA-PK siRNA #1    DNA-PK siRNA #2 
0     6     12     24        0      6    12     24        0      6     12    24 (hr)   Glucose free
ATM
mTOR
α-tubulin
p-ACC (Ser79)
DNA-PKcs
0
0.15
0.3
0.45
0.6
0.75 control siRNA
DNA-PK siRNA #1
DNA-PK siRNA #2
**
** **
**
BA
C D
Fig. 4. Inhibition or down-regulation of DNA-PKcs in M059K cells decreases AMPK activity in response to glucose depletion. (A) M059K cells were treated with or without 20 μM of
wortmannin for 1 h and then maintained in the presence or absence of glucose for the indicated times. Whole-cell lysates were prepared and subjected to immunoblotting with
anti-phospho-AMPKα, anti-AMPKα, anti-pACC, and anti-α-tubulin antibodies. (B) The amount of phospho-AMPKα was quantiﬁed by densitometry and corrected for the amount
of AMPKα in the corresponding lysate. The data shown are the mean s.d. from three separate experiments. **p 0.01. (C) M059K cells were transfected with control siRNA or
DNA-PKcs siRNA #1 and #2. After 48 h, the cells were cultured under glucose-free conditions for the indicated time periods. Whole-cell lysates were prepared and subjected to
immunoblotting with anti-DNA-PKcs, anti-phospho-AMPKα, anti-AMPKα, anti-mTOR, anti-ATM, anti-ACC, and anti-α-tubulin antibodies. (D) The amount of phospho-AMPKα
was quantiﬁed by densitometry and corrected for the amount of AMPKα in the corresponding lysate. The data shown are the mean s.d. from three separate experiments. **p 0.01.
2104 P.N. Amatya et al. / Biochimica et Biophysica Acta 1823 (2012) 2099–2108M059K cells transfected with control siRNA, DNA-PKcs siRNA #1, or
DNA-PKcs siRNA #2 were cultured under in glucose-free conditions
for 0, 6, 12, and 24 h. Whole-cell lysates were prepared and analyzed
by immunoblotting for phosphorylated AMPK and phosphorylated
ACC. As shown in Fig. 4C and D, the stimulation of AMPK (Thr172)
phosphorylation by glucose deprivation was signiﬁcantly less in
the DNA-PKcs-knockdown cells than in the control cells. ACC phos-
phorylation at Ser79 was also lower in DNA-PKcs siRNA transfected
cells than in control cells. To conﬁrm the speciﬁcity of DNA-PKcs
siRNA constructs, we checked the protein levels of homologues of
DNA-PKcs in the P13K superfamily, such as ATM or mTOR. We ob-
served that two different DNA-PKcs siRNAs (#1 and #2) did not af-
fect the levels of mTOR and ATM (Fig. 4C, 5th and 6th panel).
To further conﬁrm the role of DNA-PKcs for the activation of AMPK in
response to glucose free conditions, we compared the AMPK activity be-
tweenDNA-PKcs+/+ andDNA-PKcs−/−MEFs. As shown in Fig. 5A and B,
the basal and glucose deprivation-stimulated AMPK phosphorylation
was signiﬁcantly less in DNA-PKcs−/− MEFs than in DNA-PKcs+/+
MEFs. The AMPK activity analysis also revealed that DNA-PKcs−/−
MEFs had signiﬁcantly lower AMPK activity than DNA-PKcs+/+ MEFs
(Fig. 5C). The basal AMPK activities of DNA-PKcs−/− and DNA-PKcs+/+
MEFs were 995 22 and 1020 25 cpm, respectively. The glucose
deprivation-stimulated AMPK activities were 1160±26 and 1480±
36 cpm in DNA-PKcs−/− and DNA-PKcs+/+ MEFs, respectively. Theseresults suggest that DNA-PKcs increases glucose deprivation-stimulated
AMPK activity.
3.5. Glucose deprivation-stimulated phosphorylation of AMPK is decreased
by knockdown of DNA-PKcs in human ﬁbroblast WI38 and IMR90 cells
In order to determine if DNA-PKcs indeed contributes to the enhance-
ment of the AMPK activation, we examined the effect of DNA-PKcs
knockdown by siRNA on glucose depletion-induced AMPK activation in
primary human diploid ﬁbroblast WI38 and IMR90 cells. Western blot
analysis was performed 48 h after treating the WI38 and IMR90 cells
with either the DNA-PKcs siRNA or control siRNA. The DNA-PKcs siRNA
treatment resulted in a signiﬁcant decrease in the DNA-PKcs protein
level, compared with control siRNA transfected cells (Fig. 6A). The levels
of AMPKα phosphorylation after DNA-PKcs-siRNA transfection were
next examined. The results showed that the glucose depletion-induced
AMPKα phosphorylation was markedly suppressed in the WI38 and
IMR90 cells treatedwith the DNA-PKcs siRNA (Fig. 6A, B). The ACC phos-
phorylation analysis experiments conﬁrmed that the transfection of
DNA-PKcs siRNA reduces the level of ACC phosphorylation in response
to glucose depletion compared with the control siRNA transfection
(Fig. 6A, 4th panel). These results suggest that DNA-PKcs is involved in
the glucose deprivation-stimulated AMPK activity in primary human
diploid ﬁbroblasts.
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inhibition of DNA-PKcs in LKB1-deﬁcient HeLa cells
LKB1 is a major protein kinase involved in the phosphorylation of
AMPK under hypoxia, oxidative stress, and nutrient deprivation [14].
As our results suggested that DNA-PKcs may contribute to the phos-
phorylation of AMPK, we examined the effect of DNA-PKcs on AMPK
phosphorylation in HeLa cells, which do not express LKB1 [25]. To
test the hypothesis that DNA-PKcs functions as an activator of
AMPK in HeLa cells, HeLa cells were transfected with either control
siRNA or DNA-PKcs siRNA. After 48 h, the cells were maintained
under glucose-free conditions for various times. Whole-cell lysates
were prepared, and the phosphorylation of AMPKα was analyzed
by immunoblotting. As shown in Fig. 7A and B, under glucose-free
conditions, the phosphorylation of AMPK was signiﬁcantly reduced
in DNA-PKcs-knockdown HeLa cells compared with that in the con-
trol cells. Our results provide strong support for the involvement of
DNA-PKcs in the phosphorylation of AMPK under glucose-free
conditions.4. Discussion
Our present work provides evidence that DNA-PKcs is an impor-
tant regulator of AMPK activation in response to energy depletion.
We established that AMPK phosphorylation and AMPK activity under
glucose-depleted conditions is more pronounced in DNA-PKcs-
proﬁcient and DNA-PKcs+/+ cells than in DNA-PKcs-deﬁcient and
DNA-PKcs−/− cells. Using DNA-PKcs siRNA and the DNA-PKcs inhibi-
tors, wortmannin and Nu7441, we showed that there was a marked re-
duction in both AMPKα phosphorylation at Thr172 and AMPK activity
in response to glucose depletion in DNA-PKcs-inhibited M059K cells
and human primary ﬁbroblast WI38 and IMR90 cells, as compared
with control cells. These results suggest that DNA-PKcs is involved in
AMPK activation under glucose-depleted conditions.
The depletion of glucose, the major source of energy in a cell, is
marked by an increase in the concentration of AMP and a decrease in
the concentration of ATP, and can result from various stresses such as
nutrient deprivation, hypoxia, and oxidative stress [13]. AMPK, a protein
kinase activated by glucose depletion, is a cellular energy sensor and
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Fig. 6. AMPK activation is suppressed in DNA-PKcs-deﬁcient primary human diploid ﬁbroblasts. (A) WI38 and IMR90 cells were transfected with control siRNA or DNA-PKcs siRNA
#1. After 48 h, the cells were cultured under glucose-free conditions for the indicated time periods. Whole-cell lysates were prepared and subjected to immunoblotting with
anti-DNA-PKcs, anti-phospho-AMPKα, anti-AMPKα, anti-pACC, and anti-α-tubulin antibodies. (B) The amount of phospho-AMPKα was quantiﬁed by densitometry and corrected
for the amount of AMPKα in the corresponding lysate. The data shown are the mean s.d. from three separate experiments. **p 0.01.
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heterotrimer consisting of catalytic α subunits and regulatory β and γ
subunits [36]. The AMPKγ1 subunit binds directly to the α2 subunit at
two sites [37]. The γ subunit is essential to enzyme activity by virtue of
its binding to the C-terminus of theα subunit and its role in determiningp-AMPKα (Thr172)
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nate upstream kinase that activates AMPK in a Ca2+-dependent manner
[24–26]. Both LKB1 and CaMKKβ directly phosphorylate Thr172 of the
catalytic α subunit of AMPK.
LKB1 is not detectable in HeLa human cervical cancer cells [25].
Thus, CaMKK serves as an AMPK kinase to regulate AMPK in HeLa
cells. However, the CaMKK inhibitor STO-609 did not totally block
the phosphorylation and activation of AMPK in response to mannitol
and 2-deoxyglucose [25], which suggests that other AMPK regulato-
ry mechanisms may exist in these cells. We showed that glucose
depletion-stimulated AMPK phosphorylation was signiﬁcantly re-
duced, compared with control levels, when DNA-PKcs was inhibited
by siRNA or chemical inhibitors in HeLa cells under glucose depriva-
tion. These ﬁndings point to DNA-PKcs as a candidate for a regulator
of AMPK activity in mammalian cells. We note that the absence of
DNA-PKcs alone results in a signiﬁcantly suppression of AMPK signal
pathway, as phosphorylation of AMPKα and ACC was decreased in
DNA-PKcs-deﬁcient cells after glucose depletion. After energy is de-
pleted in a cell, AMP binds to the regulatory γ subunit of AMPK, lead-
ing to the phosphorylation of AMPKα [40], which occurs in three
distinct ways [15]: allosteric activation, enhanced phosphorylation
by the upstream kinase, and inhibition of Thr172 dephosphorylation
by protein phosphatases. These results suggest that DNA-PKcs may
be a critical scaffold protein in organizing a signaling complex for
AMPK activation in response to glucose deprivation. Therefore, we
speculate that the binding of DNA-PKcs to AMPKγ may affect AMP-
mediated allosteric activation or cause conformational changes that
inhibit the inactivation by protein phosphatases. Alternatively, DNA-
PKcsmay affect the afﬁnity of the AMPbinding site of theγ subunit. Fur-
ther studies are required to validate DNA-PKcs as a regulator of AMPK
activation in mammalian cells and to determine the regulatory mecha-
nisms of AMPK by DNA-PKcs under energy depletion.
In mammalian cells, the phosphatidylinositol 3-kinase-like ki-
nase (PIKK) family, ATM, ATR, and DNA-PK, is a protein kinase that
serves as a critical mediator of signaling pathways that facilitate
the response of mammalian cells to ionizing radiation and other
agents that induce DNA double-strand breaks [4,6,7]. Recent studies
revealed that DNA damage activates AMPK through an LKB1-indepedent
and ATM-dependent pathway [32,33], suggesting that ATM may be a
candidate for a positive regulator of AMPK in response to DNA damage.
We observed that ionizing radiation increased AMPK phosphorylation
at Thr172 in DNA-PK-proﬁcient cells, but not DNA-PK-deﬁcient cells.
These observations are novel and are consistent which the idea that
DNA-PKcs is capable of phosphorylating and activating AMPK. We also
found that speciﬁc small-molecule inhibitors of ATM (Ku55933) and
DNA-PKcs (Nu7441) decreased phosphorylation of AMPK following glu-
cose deprivation, and both inhibitors were equally effective in the
suppression of the AMPK activation under glucose-depleted condi-
tion. Thus, DNA-PKcs and ATM may redundantly the participation
of the phosphorylation of AMPK in response to metabolic stress
and DNA damage.
A recent study reported that DNA-PK appears to be critical for the
transcriptional regulation of lipogenic and gluconeogenetic genes.
DNA-PK is contributed to upstream stimulating factor (USF) complex
assemble and recruitment of its interacting proteins, which is required
for the activation of fatty acid synthase (FAS) transcription [41]. More-
over, it has been described that activated AMPK signaling negatively
regulated hepatic gluconeogenesis via DNA-PK-dependent pathway
[42]. Indeed, feeding-induced de novo lipogenesis was 60 % lower in
DNA-PK-deﬁcient SCID mice after 24 hr of feeding compared to WT
mice. Furthermore, SCID mice exhibit a low adipose tissue mass, indi-
cating of a long-term defect in feeding induced lipogenesis [41]. Thus,
it has been suggested that DNA-PK could possibly serve as a pharmaco-
logical target for obesity and diabetes treatment [43]. Our results suggest
that DNA-PK is a positive regulator of AMPK activity. Therefore, DNA-PK
may play an important role in metabolic process through transcriptionalactivation of metabolic genes and positive regulation of AMPK activity.
Our study enlarges our understanding of the mechanisms implicated in
DNA-PK′s role as a regulator of the metabolic process.
In summary, we used a yeast two-hybrid system to identify
AMPKγ1 as a DNA-PKcs-interacting protein. DNA-PKcs-deﬁcient
and DNA-PKcs−/− cells exhibited decreased AMPK activation in
response to glucose-free conditions, and the inhibition of DNA-PKcs in
DNA-PKcs-proﬁcient M059K, WI38, and IMR90 cells reduced AMPK ac-
tivity under glucose deprivation. The inhibitory effects of DNA-PKcs
knockdown on the phosphorylation of AMPK in LKB1-deﬁcient HeLa
cells are also in accord with the possibility that DNA-PKcs contributes
to glucose depletion-stimulated AMPK phosphorylation. Our data
suggested a novel functional association between DNA-PKcs and
AMPK, in which DNA-PKcs can act as an activator of AMPK under en-
ergy depletion. The detailed mechanism of the activation of AMPK by
DNA-PKcs and its possible consequences are under investigation in
our laboratory.
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